Literature DB >> 10548791

Efficacy of slow infusion of gadolinium contrast agent in three-dimensional MR coronary artery imaging.

J Zheng1, K T Bae, P K Woodard, E M Haacke, D Li.   

Abstract

The impact of the contrast infusion scheme on contrast-enhanced coronary artery imaging was investigated. The imaging technique was a retrospective respiratory-gated gradient-echo sequence. To improve the contrast between blood vessels and myocardium, an inversion pulse was applied to null the myocardial signal. Extravascular contrast agent was infused slowly during data acquisition. Two contrast infusion schemes were compared in animal and volunteer studies and with simulations. One scheme enhanced blood signals during acquisition of both peripheral and central k-space data, which resulted in a relatively flat low-pass k-space filter. The other scheme mainly enhanced blood signals during acquisition of central k-space data, which resulted in a sharp low-pass k-space filter. It is concluded that the former scheme improves the signal-to-noise ratio and edge definition of coronary arteries compared with the latter scheme. J. Magn. Reson. Imaging 1999;10:800-805. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10548791     DOI: 10.1002/(sici)1522-2586(199911)10:5<800::aid-jmri26>3.0.co;2-l

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  8 in total

1.  Imaging of an aberrant right coronary artery with retrospective respiratory-gated 3D-MR angiography.

Authors:  O M Kalinkin; P K Woodard; P A Ludbrook; F R Gutierrez
Journal:  Int J Cardiovasc Imaging       Date:  2001-02       Impact factor: 2.357

2.  Coronary-cameral fistula with double-chambered right ventricle: appearance on cardiac magnetic resonance imaging and 3D printed anatomic modeling.

Authors:  Mahati Mokkarala; David H Ballard; Robert A Wesley; Fernando R Gutierrez; Cylen Javidan-Nejad; Gautam K Singh; Pamela K Woodard; Kathryn J Lindley
Journal:  Clin Imaging       Date:  2019-11-11       Impact factor: 1.605

3.  Magnetic resonance coronary angiography with Vasovist: in-vivo T1 estimation to improve image quality of navigator and breath-hold techniques.

Authors:  Kai Nassenstein; Kai-Uwe Waltering; Sebastian Kelle; Thomas Schlosser; Frank Breuckmann; Stefan Maderwald; Peter Hunold; Eike Nagel; Jörg Barkhausen
Journal:  Eur Radiol       Date:  2007-08-14       Impact factor: 5.315

4.  Accelerated contrast-enhanced whole-heart coronary MRI using low-dimensional-structure self-learning and thresholding.

Authors:  Mehmet Akçakaya; Tamer A Basha; Raymond H Chan; Hussein Rayatzadeh; Kraig V Kissinger; Beth Goddu; Lois A Goepfert; Warren J Manning; Reza Nezafat
Journal:  Magn Reson Med       Date:  2012-03-05       Impact factor: 4.668

5.  Utility of respiratory-navigator-rejected k-space lines for improved signal-to-noise ratio in three-dimensional cardiac MR.

Authors:  Mehmet Akçakaya; Jaime L Shaw; Thomas H Hauser; Reza Nezafat
Journal:  Magn Reson Med       Date:  2012-12-11       Impact factor: 4.668

6.  Contrast-enhanced whole-heart coronary MRI with bolus infusion of gadobenate dimeglumine at 1.5 T.

Authors:  Peng Hu; Jonathan Chan; Long H Ngo; Jouke Smink; Beth Goddu; Kraig V Kissinger; Lois Goepfert; Thomas H Hauser; Neil M Rofsky; Warren J Manning; Reza Nezafat
Journal:  Magn Reson Med       Date:  2010-11-30       Impact factor: 4.668

7.  Crossover comparison of ferumoxytol and gadobenate dimeglumine for abdominal MR-angiography at 3.0 tesla: Effects of contrast bolus length and flip angle.

Authors:  Tilman Schubert; Utaroh Motosugi; Sonja Kinner; Timothy J Colgan; Samir D Sharma; Scott Hetzel; Shane Wells; Camilo A Campo; Scott B Reeder
Journal:  J Magn Reson Imaging       Date:  2016-11-10       Impact factor: 4.813

8.  Accelerated isotropic sub-millimeter whole-heart coronary MRI: compressed sensing versus parallel imaging.

Authors:  Mehmet Akçakaya; Tamer A Basha; Raymond H Chan; Warren J Manning; Reza Nezafat
Journal:  Magn Reson Med       Date:  2014-02       Impact factor: 4.668

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.